You are here

Article info

Article menu
Clinical/translational cancer immunotherapy
Original research
Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress

Authors

  • Stefanie Renken Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Takahiro Nakajima Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Isabelle Magalhaes Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenDepartment of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Jonas Mattsson Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenGloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Andreas Lundqvist Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenTheme Cancer, Patient area Head and Neck, Lung and Skin, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Elias S J Arnér Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SwedenDepartment of Selenoprotein Research and National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary PubMed articlesGoogle scholar articles
  • Rolf Kiessling Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenTheme Cancer, Patient area Head and Neck, Lung and Skin, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Stina Linnea Wickström Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenTheme Cancer, Patient area Head and Neck, Lung and Skin, Karolinska University Hospital, Stockholm, SwedenClinical Neuroscience, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Stina Linnea Wickström; stina.wickstrom{at}ki.se
View Full Text

Citation

Renken S, Nakajima T, Magalhaes I, et al
Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress
Journal for ImmunoTherapy of Cancer 2022;10:e004458. doi: 10.1136/jitc-2021-004458

Publication history

  • Accepted May 9, 2022
  • First published June 23, 2022.
Online issue publication 
January 24, 2024

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.